Often referred to as GLP-3 (RT) because of its triple-action approach, Retatrutide works differently than traditional GLP-1 therapies by interacting with three key metabolic pathways involved in appetite regulation, energy balance, and metabolism
For patients without insurance coverage, we can help you explore manufacturer savings programs, patient assistance programs, and self-pay options
No, Ozempic is not FDA-approved for weight loss, and compounded semaglutide is not FDA-approved for any use, although it may be available during shortages of other FDA-approved semaglutide medications, or when the patient needs a custom dose or formulation that isnt commercially available
This is protection mode, and your skin is literally less permeable during this phase